- E-postline.berge@uib.no
- Telefon+47 55 58 61 15
- BesøksadresseAlrek helseklynge, blokk D, Årstadveien 175009 Bergen
- PostadressePostboks 78045020 Bergen
Jeg er lege, spesialist i psykiatri og PhD i epidemiologi fra 2014 ved UiB. Jeg jobber som førsteamanuensis i Eldremedisin tilknyttet Senter for Alders og Sykehjemsmedisin og overlege ved NKS Olaviken alderpsykiatriske sykehus. Fra 2019-2022 var jeg post-doc tilknyttet LIVE@Home.Path Innovating the clinical pathway for home-dwelling people with dementia and their families. A mixed-method randomized controlled trial - Prosjektbanken (forskningsradet.no), der vi ved hjelp av et trappetrinns randomisert design undersøkte om en multikompoent intervensjon kunne bedre ressursbruk og belastning for pårørende til hjemmeboende med demens. I dette prosjektet undersøkte jeg sammen med stipendiat Marie Hidle Gedde hvordan adferdsforstyrrelser ved demens ble endret under intervensjonen og under Covid-19 pandemien.
Fra august 2020 leder jeg DARK.DEM studien Virtual darkness and digital phenotyping in specialized and municipal dementia care: The DARK.DEM randomized controlled trial. - Prosjektbanken (forskningsradet.no), der vi skal undersøke om blokkade av blått lys på kveld og natt kan dempe agitasjon og andre adferdsforstyrrelser ved demens. Vi vil også utvikle digitale biomarkører for agitasjon og andre adferdsforstyrrelser ved å korrelere data fra smartklokker med tradisjonelle psykometriske mål.
Jeg er medlem av forskningsutvalget ved IGS, driver forskerskolen i samfunnsmedisin Forskerskole i samfunnsmedisinske fag | Institutt for global helse og samfunnsmedisin | UiB og leder Faglig Forum Alrek Helseklynge Faglig forum - Alrek (alrekhelseklynge.no)
Jeg er tilknyttet undervisningsgruppen til masterprogrammet i Helse og Samfunn Helse og samfunn, master, 2 år | Universitetet i Bergen (uib.no). Jeg underviser i aldring, sosial ulikhet i helse og metode, veileder masterstudenter og har emneansvar for Den akademiske prosessen: frå idé til presentasjon | Universitetet i Bergen (uib.no)
- (2024). Feedback System Analysis of a Multicomponent Intervention on Dyads of Home-Dwelling Persons With Dementia and Their Caregivers: Results From the LIVE@ Home.Path Trial. Innovation in Aging. 13 sider.
- (2023). Access to, use of, and experiences with social alarms in home-living people with dementia: results from the LIVE@Home.Path trial. Frontiers in Aging Neuroscience.
- (2022). The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial. BMC Medicine.
- (2022). The acceptability, adoption, and feasibility of a music application developed using participatory design for home-dwelling persons with dementia and their caregivers. The “Alight” app in the LIVE@Home.Path trial. Frontiers in Psychiatry. 1-18.
- (2022). Impact of COVID-19 restrictions on behavioural and psychological symptoms in home-dwelling people with dementia: A prospective cohort study (PAN.DEM). BMJ Open.
- (2022). Gender specific early treatment for women with alcohol addiction (EWA): Impact on work related outcomes. A 25-year registry follow-up of a randomized controlled trial (RCT). Drug and Alcohol Dependence. 8 sider.
- (2022). Factors associated with formal and informal resource utilization in nursing home patients with and without dementia: cross-sectional analyses from the COSMOS trial. BMC Health Services Research. 1-10.
- (2021). Which factors increase informal care hours and societal costs among caregivers of people with dementia? A systematic review of Resource Utilization in Dementia (RUD). Health Economics Review. 15 sider.
- (2021). The consequences of COVID-19 lockdown for formal and informal resource utilization among home-dwelling people with dementia: results from the prospective PAN.DEM study. BMC Health Services Research. 1-12.
- (2021). How, Why and Where it Hurts—Breaking Down Pain Syndrome Among Nursing Home Patients With Dementia: A Cross-Sectional Analysis of the COSMOS Trial. Pain Management Nursing. 319-326.
- (2021). Genetic Dominant Variants in STUB1, Segregating in Families with SCA48, Display In Vitro Functional Impairments Indistinctive from Recessive Variants Associated with SCAR16. International Journal of Molecular Sciences.
- (2021). Factors associated with access to assistive technology and telecare in home-dwelling people with dementia: baseline data from the LIVE@Home.Path trial. BMC Medical Informatics and Decision Making. 1-14.
- (2021). Age and emotional distress during covid-19: Findings from two waves of the norwegian citizen panel. International Journal of Environmental Research and Public Health (IJERPH). 14 sider.
- (2021). Access to and interest in assistive technology for home-dwelling people with dementia during the COVID-19 pandemic (PAN.DEM). International Review of Psychiatry. 9 sider.
- (2020). The negative impact of psychotropic drug use on quality of life in nursing home patients at different stages of dementia: Cross-sectional analyses from the COSMOS trial. Journal of the American Medical Directors Association. 1623-1628.
- (2020). Less is more: The impact of deprescribing psychotropic drugs on behavioral and psychological symptoms and daily functioning in nursing home patients. Results from the Cluster-Randomized Controlled COSMOS Trial. The American journal of geriatric psychiatry. 304-315.
- (2020). LIVE@Home.Path--innovating the clinical pathway for home-dwelling people with dementia and their caregivers: Study protocol for a mixed-method, stepped-wedge, randomized controlled trial. Trials. 1-16.
- (2018). Diabetes is associated with decreased migraine risk: A nationwide cohort study. Cephalalgia. 1759-1764.
- (2016). Health anxiety and risk of ischaemic heart disease: A prospective cohort study linking the Hordaland Health Study (HUSK) with the Cardiovascular Diseases in Norway (CVDNOR) project. BMJ Open. 9 sider.
- (2015). The prospective association between health anxiety and cancer detection: A cohort study linking the Hordaland Health Study (HUSK) with the Norwegian Cancer Registry. Journal of Psychosomatic Research. 148-152.
- (2015). Depression in persons with diabetes by age and antidiabetic treatment: A crosssectional analysis with data from the hordaland health study. PLOS ONE. 15 sider.
- (2015). Attempts to improve and confidence in improving health behaviour in 40-49 year olds with and without coronary heart disease: The Hordaland Health Study. European Journal of Cardiovascular Nursing. e60-e69.
- (2014). Is depression a risk factor for diabetic foot ulcers? 11-years follow-up of the Nord-Trøndelag Health Study (HUNT). Journal of Diabetes and its Complications (JDC). 20-25.
- (2013). Prevalence and characteristics of depressive disorders in type 1 diabetes. BMC Research Notes.
- (2013). Does diabetes have a protective effect on migraine? Epidemiology. 129-134.
- (2013). Co-morbidity between diabetes, migraine and depression. Norsk Epidemiologi. 83-87.
- (2012). Risk of depression in diabetes is highest for young persons using oral anti-diabetic agents. Diabetic Medicine. 509-514.
- (2023). Helsetjenester til personer med demens.
- (2023). Forskernatt, søvnens makt: ungdom, overgang, alderdom. .
- (2023). Forskernatt «Søvnens makt: Ungdom – overgang – alderdom».
- (2023). Virtual darkness and digital phenotyping in specialized and municipal dementia care. The DARK.DEM trial.
- (2023). The effectiveness of a multicomponent intervention on caregiver burden and informal care time in home-dwelling people with dementia and their caregivers. Results from the stepped wedge randomized controlled LIVE@Home.Path trial.
- (2023). Kronoterapi mot adferdsforstyrrelser ved demens.
- (2023). Chronotheraphy for behavioral and psychological symptoms of dementia.
- (2022). Konsekvenser av covid-19 restriksjonene for eldre og personer med demens.
- (2022). Cost-effectiveness of LIVE@Home.Path care model for home-dwelling persons with dementia: preliminary results from a stepped-wedge randomized controlled trial.
- (2022). Brighter Age: Alderspsykiatri i nytt lys.
- (2016). Hva gikk galt hos legen? Når dialogen svikter. Spartacus.
- (2022). Psykose og depresjon hos eldre under koronapandemien. Forskning.no.
- (2021). Eldre har også lidd under pandemien. Bergens Tidende.
- (2020). Politikerne hykler om velferdsteknologi. Vårt land.
- (2020). Politikerne hykler om velferdsteknologi. Vårt land.
- (2020). Intensive Medicine and Nursing Home Care in Times of SARS CoV-2: A Norwegian Perspective. The American journal of geriatric psychiatry. 792-793.
- (2014). Depression and migraine comorbid to diabetes.
- (2024). Søvn gjennom livsløpet: Kan søvnproblemer øke risikoen for demens? Med overlege og førsteamanuensis Line Iden Berge.
- (2023). Light exposure, sleep quality, and sleepiness as predictors of memory decline in older adults: A cohort study from Norway .
- (2021). Multicomponent intervention with medication reviews impact on psychotropic drug use and behavioural and psychological symptoms in home-dwelling persons with dementia. .
- (2021). LIVE@Home.Path: Innovating the clinical pathway for home-dwelling people with dementia and caregivers .
- (2021). Impact of medication review on psychotropic drug use for behavioral and psychological symptoms of home-dwelling persons with dementia. .
- (2020). Access to and interest in assistive technology for home-dwelling people with dementia under COVID-19.
- (2019). LIVE@Home.Path.
- (2019). Ethics, privacy and regulations in research including home-dwelling people with dementia. .
- (2019). Digital Assessments for Individualized Dementia Care.
- (2019). Alight: The development and pilot testing of a prototype tablet application for elderly persons with affective disorders or cognitive impairment. A collaboration between patients and caregivers, clinical, academic and commercial organizations .
- (2020). Corrigendum: Sensing Technology to Monitor Behavioral and Psychological Symptoms and to Assess Treatment Response in People With Dementia. A Systematic Review (Frontiers in Pharmacology, (2020), 10, (1699), 10.3389/fphar.2019.01699). Frontiers in Pharmacology.
- (2020). Sensing technology to monitor behavioral and psychological symptoms and to assess treatment response in people with dementia: A systematic review. Frontiers in Pharmacology. 1-13.
- (2015). Comorbidity between type 2 diabetes and depression in the adult population: directions of the association and its possible pathophysiological mechanisms. International Journal of Endocrinology. 7 sider.
-The LIVE@HOme.Path trial Innovating the clinical pathway for home-dwelling people with dementia and their families. A mixed-method randomized controlled trial - Prosjektbanken (forskningsradet.no)
-The DARK.DEM trial Virtual darkness and digital phenotyping in specialized and municipal dementia care: The DARK.DEM randomized controlled trial. - Prosjektbanken (forskningsradet.no)